Carl Byrnes
Stock Analyst at Northland Securities
(0.30)
# 4,463
Out of 4,690 analysts
284
Total ratings
36.9%
Success rate
-3.4%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings | Maintained: Buy | $7.5 | $2.23 | +236.32% | 3 | Apr 24, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | $10 → $6 | $4.50 | +33.33% | 27 | Apr 17, 2026 | |
| SPRY ARS Pharmaceuticals | Maintained: Buy | $25 | $5.89 | +324.45% | 2 | Apr 15, 2026 | |
| RCEL AVITA Medical | Maintained: Buy | $10 | $10.35 | -3.38% | 2 | Mar 26, 2026 | |
| BLFS BioLife Solutions | Reiterated: Buy | $34 | $36.38 | -6.54% | 37 | Mar 24, 2026 | |
| TLSI TriSalus Life Sciences | Rated: Buy | $13 → $8 | $4.83 | +65.63% | 5 | Mar 23, 2026 | |
| MDAI Spectral AI | Maintained: Buy | $6 | $1.57 | +282.17% | 12 | Mar 19, 2026 | |
| SNWV SANUWAVE Health | Maintained: Buy | $55 | $4.68 | +1,076.47% | 4 | Mar 16, 2026 | |
| INDV Indivior Pharmaceuticals | Maintained: Buy | $50 | $34.87 | +43.39% | 12 | Feb 27, 2026 | |
| BWAY BrainsWay | Maintained: Buy | $12 → $15 | $14.30 | +4.90% | 14 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.95 | +102.02% | 18 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $4 | $0.3266 | +1,124.74% | 39 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.6901 | n/a | 4 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 → $1.25 | $13.97 | n/a | 12 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.84 | n/a | 1 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $1 | $0.0001 | n/a | 24 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $2 | $0.0001 | n/a | 24 | Nov 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $2 | $32.36 | n/a | 30 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.25 | n/a | 12 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $66.58 | n/a | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $16.67 | n/a | 1 | Oct 22, 2018 |
Connect Biopharma Holdings
Apr 24, 2026
Maintained: Buy
Price Target: $7.5
Current: $2.23
Upside: +236.32%
MiMedx Group
Apr 17, 2026
Maintained: Buy
Price Target: $10 → $6
Current: $4.50
Upside: +33.33%
ARS Pharmaceuticals
Apr 15, 2026
Maintained: Buy
Price Target: $25
Current: $5.89
Upside: +324.45%
AVITA Medical
Mar 26, 2026
Maintained: Buy
Price Target: $10
Current: $10.35
Upside: -3.38%
BioLife Solutions
Mar 24, 2026
Reiterated: Buy
Price Target: $34
Current: $36.38
Upside: -6.54%
TriSalus Life Sciences
Mar 23, 2026
Rated: Buy
Price Target: $13 → $8
Current: $4.83
Upside: +65.63%
Spectral AI
Mar 19, 2026
Maintained: Buy
Price Target: $6
Current: $1.57
Upside: +282.17%
SANUWAVE Health
Mar 16, 2026
Maintained: Buy
Price Target: $55
Current: $4.68
Upside: +1,076.47%
Indivior Pharmaceuticals
Feb 27, 2026
Maintained: Buy
Price Target: $50
Current: $34.87
Upside: +43.39%
BrainsWay
Jan 22, 2026
Maintained: Buy
Price Target: $12 → $15
Current: $14.30
Upside: +4.90%
Nov 14, 2025
Maintained: Buy
Price Target: $10
Current: $4.95
Upside: +102.02%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $4
Current: $0.3266
Upside: +1,124.74%
Aug 28, 2025
Maintained: Buy
Price Target: $5
Current: $0.6901
Upside: n/a
Jul 19, 2023
Rated: Hold
Price Target: $2 → $1.25
Current: $13.97
Upside: n/a
May 22, 2023
Initiated Coverage: Buy
Price Target: $8
Current: $1.84
Upside: n/a
Jan 6, 2023
Downgraded: Sell
Price Target: $8 → $1
Current: $0.0001
Upside: n/a
Nov 23, 2022
Maintained: Buy
Price Target: $10 → $2
Current: $0.0001
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $4 → $2
Current: $32.36
Upside: n/a
May 14, 2020
Rated: Hold
Price Target: n/a
Current: $2.25
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: $45
Current: $66.58
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $16.67
Upside: n/a